{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:47:45Z","timestamp":1783435665173,"version":"3.54.6"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.kint.2024.08.020","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T06:28:33Z","timestamp":1724912913000},"page":"1158-1169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chronic endothelial dopamine receptor stimulation improves endothelial function and hemodynamics in autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"106","author":[{"given":"Audrey","family":"Dumont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouad","family":"Hamzaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0664-1274","authenticated-orcid":false,"given":"D\u00e9borah","family":"Groussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Iacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Remy-Jouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Hanoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Le Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Enzensperger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Dieter","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvanie","family":"Renet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Dumesnil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"L\u00e9v\u00eaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Duflot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ry","family":"Brunel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Michel-Despr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Audr\u00e9zet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robinson","family":"Joannid\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5953-5785","authenticated-orcid":false,"given":"Dominique","family":"Guerrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Bellien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2024.08.020_bib1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"issue":"suppl 4","key":"10.1016\/j.kint.2024.08.020_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ndt\/gfu017","article-title":"Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry","volume":"29","author":"Spithoven","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.08.020_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1573402111309010002","article-title":"Cardiovascular complications in autosomal dominant polycystic kidney disease","volume":"9","author":"Ecder","year":"2013","journal-title":"Curr Hypertens Rev"},{"key":"10.1016\/j.kint.2024.08.020_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1573402111309010007","article-title":"The genetics of vascular complications in autosomal dominant polycystic kidney disease (ADPKD)","volume":"9","author":"Rossetti","year":"2013","journal-title":"Curr Hypertens Rev"},{"key":"10.1016\/j.kint.2024.08.020_bib5","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1681\/ASN.2013040417","article-title":"The mutation, a key determinant of phenotype in ADPKD","volume":"24","author":"Harris","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.08.020_bib6","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.08.020_bib7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrneph.2010.97","article-title":"Polycystins and renovascular mechanosensory transduction","volume":"6","author":"Patel","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2024.08.020_bib8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.08.020_bib9","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.bbadis.2011.01.011","article-title":"Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease","volume":"1812","author":"Terryn","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"suppl 1","key":"10.1016\/j.kint.2024.08.020_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000463063","article-title":"Polycystic kidney disease and the vasopressin pathway","volume":"70","author":"Van Gastel","year":"2017","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.kint.2024.08.020_bib11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/CIRCULATIONAHA.107.710111","article-title":"Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1","volume":"117","author":"Nauli","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2024.08.020_bib12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCRESAHA.108.192765","article-title":"Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades","volume":"104","author":"AbouAlaiwi","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2024.08.020_bib13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.2014.241","article-title":"Polycystin deficiency induces dopamine-reversible alterations in flow-mediated dilatation and vascular nitric oxide release in humans","volume":"87","author":"Lorthioir","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.08.020_bib14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/HYPERTENSIONAHA.111.172080","article-title":"Dopamine receptor type 5 in the primary cilia has dual chemo- and mechano-sensory roles","volume":"58","author":"Abdul-Majeed","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2024.08.020_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fphys.2014.00072","article-title":"Roles of dopamine receptor on chemosensory and mechanosensory primary cilia in renal epithelial cells","volume":"5","author":"Upadhyay","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.kint.2024.08.020_bib16","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00018-013-1483-1","article-title":"Cilioplasm is a cellular compartment for calcium signaling in response to mechanical and chemical stimuli","volume":"71","author":"Jin","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.kint.2024.08.020_bib17","first-page":"63","article-title":"Ciliotherapy: a novel intervention in polycystic kidney disease","volume":"11","author":"Kathem","year":"2014","journal-title":"J\u00a0Geriatr Cardiol"},{"key":"10.1016\/j.kint.2024.08.020_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1472-8206.2012.01028.x","article-title":"Rotigotine transdermal patch for the treatment of Parkinson\u2019s disease","volume":"27","author":"Perez-Lloret","year":"2013","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.kint.2024.08.020_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00210-008-0341-4","article-title":"The in\u00a0vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson\u2019s disease","volume":"379","author":"Scheller","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.kint.2024.08.020_bib20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.clinthera.2014.01.021","article-title":"From bench to bedside: an overview of rotigotine for the treatment of restless legs syndrome","volume":"36","author":"Bogan","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.kint.2024.08.020_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.08.020_bib22","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/humu.22103","article-title":"Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients","volume":"33","author":"Audr\u00e9zet","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.kint.2024.08.020_bib23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41581-023-00747-4","article-title":"Diagnosis of cardiovascular disease in patients with chronic kidney disease","volume":"19","author":"Zoccali","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2024.08.020_bib24","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.kint.2024.08.020_bib25","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.kint.2024.08.020_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.kint.2016.10.018","article-title":"Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease","volume":"91","author":"Torres","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.08.020_bib27","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2215\/CJN.16871020","article-title":"Overweight and obesity and progression of ADPKD","volume":"16","author":"Nowak","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.08.020_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/kidneydial2010013","article-title":"Obesity, weight loss, lifestyle interventions, and autosomal dominant polycystic kidney disease","volume":"2","author":"Steele","year":"2022","journal-title":"Kidney Dial"},{"key":"10.1016\/j.kint.2024.08.020_bib29","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1681\/ASN.2006060603","article-title":"Water for ADPKD? probably, yes","volume":"17","author":"Torres","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.08.020_bib30","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","article-title":"Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a bayesian network meta-analysis of randomized clinical trials","volume":"67","author":"Xie","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.08.020_bib31","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/j.1600-6143.2011.03697.x","article-title":"Immunosuppressant regimen based on sirolimus decreases aortic stiffness in renal transplant recipients in comparison to cyclosporine","volume":"11","author":"Joannid\u00e8s","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2024.08.020_bib32","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/CIRCULATIONAHA.111.070680","article-title":"Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension","volume":"125","author":"Bellien","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2024.08.020_bib33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000502999","article-title":"Rapid progression of autosomal dominant polycystic kidney disease: urinary biomarkers as predictors","volume":"50","author":"Messchendorp","year":"2019","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2024.08.020_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2377-10-86","article-title":"Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch","volume":"10","author":"H\u00f6gl","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.kint.2024.08.020_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14656566.2013.758251","article-title":"Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: a post-hoc analysis of patients taking 1 - 3 mg\/24 h for up to 5 years","volume":"14","author":"Dohin","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.kint.2024.08.020_bib36","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1161\/HYPERTENSIONAHA.122.19057","article-title":"Endothelium-specific deficiency of polycystin-1 promotes hypertension and cardiovascular disorders","volume":"79","author":"Hamzaoui","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2024.08.020_bib37","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/s41598-020-58393-w","article-title":"5\/6 Nephrectomy induces different renal, cardiac and vascular consequences in 129\/Sv and C57BL\/6JRj mice","volume":"10","author":"Hamzaoui","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2024.08.020_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/dvdy.20557","article-title":"Monocilia on chicken embryonic endocardium in low shear stress areas","volume":"235","author":"Van der Heiden","year":"2006","journal-title":"Dev Dyn"},{"key":"10.1016\/j.kint.2024.08.020_bib39","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","article-title":"Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease","volume":"64","author":"Wang","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.08.020_bib40","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1053\/j.ajkd.2004.01.011","article-title":"Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease","volume":"43","author":"Kocaman","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.08.020_bib41","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.semnephrol.2019.10.009","article-title":"Hypoxia and endothelial dysfunction in autosomal-dominant polycystic kidney disease","volume":"39","author":"Theodorakopoulou","year":"2019","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2024.08.020_bib42","first-page":"F1198","article-title":"Endothelial dysfunction and oxidative stress in polycystic kidney disease","volume":"307","author":"Klawitter","year":"2014","journal-title":"Am J Physiol"},{"key":"10.1016\/j.kint.2024.08.020_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000353730","article-title":"Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease","volume":"123","author":"Kocyigit","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.kint.2024.08.020_bib44","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ndt\/gfw013","article-title":"Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease","volume":"32","author":"Nowak","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.08.020_bib45","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2024.08.020_bib46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/phar.1421","article-title":"Review of tolvaptan for autosomal dominant polycystic kidney disease","volume":"34","author":"Baur","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.kint.2024.08.020_bib47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2215\/CJN.0000000000000049","article-title":"Effects of octreotide-long-acting release added-on tolvaptan in patients with autosomal dominant polycystic kidney disease: pilot, randomized, placebo-controlled, cross-over trial","volume":"18","author":"Trillini","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.08.020_bib48","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/1570161118999200918094809","article-title":"Cardiovascular risk and quality of life in autosomal dominant polycystic kidney disease patients in therapy with tolvaptan: a pilot study","volume":"19","author":"Lai","year":"2021","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.kint.2024.08.020_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijcard.2018.10.063","article-title":"Left ventricular dysfunction in ADPKD and effects of octreotide-LAR: a cross-sectional and longitudinal substudy of the ALADIN trial","volume":"275","author":"Spinelli","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.kint.2024.08.020_bib50","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.clinthera.2015.01.013","article-title":"Pharmacokinetic properties and tolerability of rotigotine transdermal patch after repeated-dose application in healthy Korean volunteers","volume":"37","author":"Kim","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.kint.2024.08.020_bib51","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40265-015-0377-y","article-title":"An update on pharmacological, pharmacokinetic properties and drug\u2013drug interactions of rotigotine transdermal system in Parkinson\u2019s disease and restless legs syndrome","volume":"75","author":"Elshoff","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.kint.2024.08.020_bib52","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/cb200349v","article-title":"A\u00a0chemical screen identifies class a g-protein coupled receptors as regulators of cilia","volume":"7","author":"Avasthi","year":"2012","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.kint.2024.08.020_bib53","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s13318-015-0273-6","article-title":"Pharmacokinetics, safety, and tolerability of rotigotine transdermal system in healthy Japanese and Caucasian subjects following multiple-dose administration","volume":"41","author":"Cawello","year":"2016","journal-title":"Eur J Drug Metab Pharmacokinet"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824006264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824006264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T20:56:19Z","timestamp":1735332979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253824006264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0085253824006264"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2024.08.020","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic endothelial dopamine receptor stimulation improves endothelial function and hemodynamics in autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}